The Latest Breaking News from INSPIRE

The decision of Department of Science and Technology, New Delhi, to scrap Kishore Vaigyanik Protsahan Yojna (KVPY) fellowship from this year has caused disappointment among school teachers who were keenly anticipating its conduct in Tamil for the convenience of the students following the Supreme Court's intervention last year.

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Manufacturer of transdermal cannabinoid therapies for neuropsychiatric disorders, Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) reported Tuesday financial results for the fourth quarter and full year ended December 31, 2021.

Manufacturer of transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, Zynerba Pharmaceuticals, Inc.

Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced the first six-month interim analysis results from INSPIRE study evaluating the Real-World Effectiveness and Safety of Alofisel (darvadstrocel).

It would study ionosphere dynamics and sun's coronal heating processes

INSPIRESat-1 one of the three satellites to be launched aboard PSLV C-52 tomorrow